Eterna Therapeutics (id:6070 ERNA)
0.520 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 3:49:18 PM)
Exchange closed, opens in 1 day 17 hours
-10.21 USD (-10.21%)
-26.75 USD (-26.75%)
-53.15 USD (-53.15%)
-74.88 USD (-74.88%)
-50.00 USD (-50.00%)
-99.48 USD (-99.48%)
-99.93 USD (-99.93%)
-99.99 USD (-99.99%)
About Eterna Therapeutics
Market Capitalization 31.58M
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
| Headquarters (address) |
1035 Cambridge Street Cambridge 02141 MA United States |
| Phone | 212 582 1199 |
| Website | https://eternatx.com |
| Employees | 8 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | ERNA |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 0.520 - 2.63 |
| Market Capitalization | 31.58M |
| P/E trailing | -0.127 |
| P/E forward | -0.064 |
| Price/Sale | 194.94 |
| Price/Book | 1.49 |
| Beta | 7.77 |
| EPS | -8.31 |
| EPS United States (ID:6, base:3402) | 24.25 |